Green spectrofluorimetric method for quantification of sodium oxybate in pharmaceutical and plasma samples
Abstract Sodium oxybate is a newly approved oral treatment for narcolepsy-related cataplexy and excessive daytime sleepiness. It has been misused recreationally and implicated in drug-facilitated crimes. In this study, a highly sensitive and environmentally benign quenching spectrofluorimetric metho...
Saved in:
| Main Authors: | Reem M. Alnemari, Farooq M. Almutairi, Muneef M. Aldhafeeri, Maram H. Abduljabbar, Rami M. Alzhrani, Yusuf S. Althobaiti, Musaad M. Althobaiti, Sherif Ramzy, Atiah H. Almalki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01644-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
by: Xiaodan Zhou, et al.
Published: (2024-11-01) -
RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates
by: Asim Roy, et al.
Published: (2024-12-01) -
How once-nightly sodium oxybate is processed in the body in healthy volunteers: a plain language summary
by: Richard Bogan, et al.
Published: (2025-03-01) -
Understanding the Patient Experience with Twice-Nightly Sodium Oxybate Therapy for Narcolepsy: A Social Listening Experiment
by: Maria Picone, et al.
Published: (2024-11-01) -
A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy
by: Deborah A. Nichols, et al.
Published: (2025-06-01)